The pharma 5.0 market is valued at USD 8.05 billion in 2025 at a CAGR of 22.07%. The market is moving forward, with the incorporation of AI, robotics, digital twins, advanced analytics, connected manufacturing systems, and human-centric production models. Deepa Pandey, Sr. Research Analyst, researched applications for competitive benchmarking or strategic decision-making for pharmaceutical companies, biotechnology companies, technology providers, healthcare organisations, and investors.
